Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis with Subclinical Coronary Artery Atherosclerosis

Arthritis and Rheumatology

Volumn 68, Issue 1, 2016, Pages 92-102

  Winchester, Robert ^a   Giles, Jon T ^a   Nativ, Simona ^a   Downer, Kendall ^a   Zhang, Hui Zhu ^a   Bag Ozbek, Ayse ^a   Zartoshti, Afshin ^a   Bokhari, Sabahat ^a   Bathon, Joan M ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CD14 ANTIGEN; CD16 ANTIGEN; CD28 ANTIGEN; CD57 ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA DRB1 ANTIGEN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TUMOR NECROSIS FACTOR INHIBITOR; CD56 ANTIGEN; FC RECEPTOR;

ALLELE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; ADULT; AGED; ASYMPTOMATIC DISEASE; BLOOD VESSEL CALCIFICATION; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; STATISTICAL MODEL; T LYMPHOCYTE SUBPOPULATION; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; ANTIGENS, CD14; ANTIGENS, CD56; ANTIGENS, CD57; ARTHRITIS, RHEUMATOID; ASYMPTOMATIC DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; LOGISTIC MODELS; MALE; MIDDLE AGED; MONOCYTES; MULTIVARIATE ANALYSIS; RECEPTORS, IGG; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 84951953357     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39419     Document Type: Article

References (51)

1. Del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A., High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
2. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al., The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94.
3. Goronzy JJ, Weyand CM., Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther 2009; 11: 249.
4. Gregersen PK, Silver J, Winchester RJ., The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-13.
5. Yu DT, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG., Peripheral blood Ia-positive T cells: increases in certain diseases and after immunization. J Exp Med 1980; 151: 91-100.
6. Waase I, Kayser C, Carlson PJ, Goronzy JJ, Weyand CM., Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum 1996; 39: 904-13.
7. Schmidt D, Martens PB, Weyand CM, Goronzy JJ., The repertoire of CD4+ CD28- T cells in rheumatoid arthritis. Mol Med 1996; 2: 608-18.
8. Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, Machalinski B, et al., The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis. Arthritis Res Ther 2003; 5: R210-3.
9. Sallusto F, Geginat J, Lanzavecchia A., Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22: 745-63.
10. Appay V., The physiological role of cytotoxic CD4+ T-cells: the holy grail? Clin Exper Immunol 2004; 138: 10-3.
11. Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, et al., De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 2003; 93: 106-13.
12. James EA, Rieck M, Pieper J, Gebe JA, Yue BB, Tatum M, et al., Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy. Arthritis Rheumatol 2014; 66: 1712-22.
13. nullCD4+ T cells: characterization of an effector memory T-cell population in patients with rheumatoid arthritis. Scand J Immunol 2004; 60: 199-208.
14. Maeda T, Yamada H, Nagamine R, Shuto T, Nakashima Y, Hirata G, et al., Involvement of CD4+,CD57+ T cells in the disease activity of rheumatoid arthritis. Arthritis Rheum 2002; 46: 379-84.
15. Imberti L, Sottini A, Signorini S, Gorla R, Primi D., Oligoclonal CD4+ CD57+ T-cell expansions contribute to the imbalanced T-cell receptor repertoire of rheumatoid arthritis patients. Blood 1997; 89: 2822-32.
16. high+ (CD57+) T cells in patients with rheumatoid arthritis. Arthritis Rheum 1997; 40: 237-48.
17. Jabri B, Selby JM, Negulescu H, Lee L, Roberts AI, Beavis A, et al., TCR specificity dictates CD94/NKG2A expression by human CTL [published erratum appears in Immunity 2002;17:835]. Immunity 2002; 17: 487-99.
18. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al., Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: e74-80.
19. bright CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum 2012; 64: 671-7.
20. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, et al., SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 2011; 118: e50-61.
21. Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, et al., Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011; 118: e16-31.
22. Hansson GK, Hermansson A., The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-12.
23. Ammirati E, Cianflone D, Vecchio V, Banfi M, Vermi AC, De Metrio M, et al., Effector memory T cells are associated with atherosclerosis in humans and animal models. J Am Heart Assoc 2012; 1: 27-41.
24. Ozaki Y, Imanishi T, Taruya A, Aoki H, Masuno T, Shiono Y, et al., Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris. Circ J 2012; 76: 2412-8.
25. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al., 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
26. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R., Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-32.
27. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL., Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
28. Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, et al., Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009; 68: 954-60.
29. Wolfe F., Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation. J Rheumatol 2001; 28: 982-9.
30. Winchester R, Wiesendanger M, O'Brien W, Zhang HZ, Maurer MS, Gillam LD, et al., Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis. J Immunol 2011; 187: 1006-14.
31. Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, Greenberg DA, et al., HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 2012; 64: 1134-44.
32. Balandraud N, Picard C, Reviron D, Landais C, Toussirot E, Lambert N, et al., HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis. PLoS One 2013; 8: e64108.
33. Winchester R., Reshaping Cinderella's slipper: the shared epitope hypothesis. Arthritis Res Ther 2006; 8: 109.
34. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al., Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012; 44: 291-6.
35. Schiffrin EL., The immune system: role in hypertension. Can J Cardiol 2013; 29: 543-8.
36. Harrison DG., The immune system in hypertension. Trans Am Clin Climatol Assoc 2014; 125: 130-8.
37. Hansson GK, Holm J, Jonasson L., Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169-75.
38. Stemme S, Holm J, Hansson GK., T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992; 12: 206-11.
39. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al., Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883-8.
40. Moore KJ, Tabas I., Macrophages in the pathogenesis of atherosclerosis. Cell 2011; 145: 341-55.
41. null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 2007; 50: 1450-8.
42. Hansson GK, Zhou X, Tornquist E, Paulsson G., The role of adaptive immunity in atherosclerosis. Ann N Y Acad Sci 2000; 902: 53-62.
43. Libby P., Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
44. null T cells in rheumatoid arthritis. Arthritis Res Ther 2007; 9: R87.
45. Hansson GK, Libby P., The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6: 508-19.
46. + T cells are associated with subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. PLoS One 2013; 8: e71498.
47. Bergstrom I, Backteman K, Lundberg A, Ernerudh J, Jonasson L., Persistent accumulation of interferon-γ-producing CD8+CD56+ T cells in blood from patients with coronary artery disease. Atherosclerosis 2012; 224: 515-20.
48. Strioga M, Pasukoniene V, Characiejus D., CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology 2011; 134: 17-32.
49. Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, Bickel C, et al., CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels. Thromb Haemost 2004; 92: 419-24.
50. Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, et al., CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004; 109: 2744-8.
51. Warrington KJ, Kent PD, Frye RL, Lymp JF, Kopecky SL, Goronzy JJ, et al., Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 2005; 7: R984-91.